- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Promoting Appropriate PDT Prescribing Through Provider Education and Support
Panelists highlight the need for education and support to help clinicians appropriately prescribe prescription digital therapeutics (PDTs).
EP: 1.Differentiating PDTs from Wellness Apps and Evaluating Efficacy
EP: 2.Payer Needs and Strategies for Evaluating and Covering PDTs
EP: 3.Payers Review Process and Effective Strategies for PDT Coverage
EP: 4.Stakeholder Involvement and Evidence Requirements for PDT Coverage Decisions
EP: 5.Dawn of the Age of Adopting PDTs
EP: 6.Identifying the Most Impactful Disease Areas and Patient Populations for PDTs
EP: 7.Evolving Commercialization and Distribution Models for PDTs
EP: 8.Promoting Appropriate PDT Prescribing Through Provider Education and Support
EP: 9.Optimizing Provider Education, Utilization Monitoring, and Value-Based Contracts for PDTs
EP: 10.Optimizing Benefit Design and Implementation for Improved PDT Access
EP: 11.PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access
Neoadjuvant Chemotherapy Becomes Leading Initial Treatment for Advanced Epithelial Ovarian Cancer
October 22nd 2024By 2021, neoadjuvant chemotherapy followed by interval cytoreductive surgery became the most common initial treatment for patients with advanced epithelial ovarian cancer, overtaking primary cytoreductive surgery.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
